Corcept Therapeutics
CORT
#2372
Rank
NZ$14.05 B
Marketcap
NZ$128.46
Share price
-4.14%
Change (1 day)
-4.25%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): NZ$11.97 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are NZ$0.83 Billion. In 2025 the company made an earning of NZ$80.01 Million a decrease over its 2024 earnings that were of NZ$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$11.97 M-85.03%
2025 NZ$80.01 M-67.29%
2024 NZ$0.24 B27.66%
2023 NZ$0.19 B-4.75%
2022 NZ$0.20 B-9.51%
2021 NZ$0.22 B-2.91%
2020 NZ$0.22 B14.87%
2019 NZ$0.19 B24.71%
2018 NZ$0.15 B69.32%
2017 NZ$94.4 M419.26%
2016 NZ$18.18 M-395.64%
2015 -NZ$6.15 Million-87.53%
2014 -NZ$49.34 Million-33.44%
2013 -NZ$74.12 Million
2011 -NZ$57.75 Million17.84%
2010 -NZ$49.01 Million35.5%
2009 -NZ$36.17 Million2.84%
2008 -NZ$35.17 Million60.81%
2007 -NZ$21.87 Million-52.14%
2006 -NZ$45.7 Million20.91%
2005 -NZ$37.8 Million31.87%
2004 -NZ$28.66 Million60.54%
2003 -NZ$17.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$33.43 B 292,187.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$22.58 B 197,292.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$12.33 B 107,737.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$62.10 B 542,744.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.73 B 119,962.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$20.24 B 176,824.28%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-NZ$86.91 Million-859.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.14 B 1,139.48%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.26 B 2,228.02%๐Ÿ‡บ๐Ÿ‡ธ USA